EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis

Heikki Laurikainen, Reetta-Liina Armio, Lauri Tuominen, Mikko Nyman, Anna Kirjavainen, Johan Rajander, Merja Haaparanta-Solin, Olof Solin, Jarmo Hietala

Schizophrenia Bulletin · 10.04.2026 · 52 (3)

DOI: 10.1093/schbul/sbag038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 05.05.2026. Verfasst von Heikki Laurikainen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Turku PET Centre, University of Turku and Turku University Hospital, 20521, Turku, Finland. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Psychotic Disorders, Sex Characteristics, Endocannabinoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union under the 7th Framework Programme, Turku University Central Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis A sex difference in the clinical presentation of schizophrenia is well known. Males have on average an earlier symptom onset, worse functional capacity, and more negative symptoms. Studies on the neurobiological correlates of psychosis show that brain endocannabinoid system (ECS) is dysregulated in male patients with first-episode psychosis (FEP). We now evaluated whether the brain ECS is also altered in female patients with FEP. Study Design In this cross-sectional case–control study, brain CB1R availability was measured in 39 participants, including groups of male and female patients with FEP, and healthy control participants (HC) of similar age and sex (n = 8-11/group). Brain CB1R availability was measured with the selective CB1R radiotracer [18F]FMPEP-d2 and positron emission tomography. Arterial input derived distribution volumes (VT) were extracted from regions of interest (ROI) representing the anterior cingulate cortex, hippocampus, thalamus, and putamen. Study Results Within-subjects analyses showed a regionally differential effect of ROI*sex*group (ε = 0.77; F(2.31,80.85) = 4.31, P = .013). Simple effect analyses indicates that male FEP had significantly lower overall CB1R VT when compared to male HC (F(1,17) = 15.64, pFWER = 0.018), while female FEP VT did not differ from female HC (F(1,18) = 0.12, pFWER = 1). A regionally specific difference of VT between males and females with FEP (F(3,48) = 3.43, P = .024) did not survive the correction for multiple comparisons (pFWER = 0.14). Conclusions The availability of brain CB1R is differentially altered in males and females with early psychosis. Sex-related neurobiological patterns including the ECS may offer new treatment strategies for alleviating the core symptoms of psychotic disorders in male and female patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Psychotic DisordersSex CharacteristicsEndocannabinoidsThalamusHippocampusGyrus CinguliPutamenBrainHumansMaleFemaleAdultPositron-Emission TomographyYoung AdultCase-Control StudiesCross-Sectional StudiesAdolescent

Stichwörter der Autor:innen

CB1-receptorearly psychosissex difference

Substanzen

Receptor, Cannabinoid, CB1Endocannabinoids

Autor:innen und Institutionen

  • Turku PET Centre, University of Turku and Turku University Hospital, 20521, Turku, Finland.
  • Department of Psychiatry, University of Turku and Turku University Hospital, 20520, Turku, Finland.
  • University of Ottawa Institute of Mental Health Research, K1Z 7K4, Ottawa, ON, Canada.
  • Department of Psychiatry, Faculty of Medicine, University of Ottawa, K1Z 7K4, Ottawa, ON, Canada.
  • Department of Radiology, Turku University Hospital & University of Turku, 20521, Turku, Finland.
  • Accelerator Laboratory, Turku PET Centre, Åbo Akademi University, 20521, Turku, Finland.

Förderung

  • European Union under the 7th Framework Programme
  • Turku University Central Hospital

Zitieren

APA

Laurikainen, H., Armio, R. L., Tuominen, L., Nyman, M., Kirjavainen, A., Rajander, J., Haaparanta-Solin, M., Solin, O., & Hietala, J. (2026). The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis. Schizophrenia Bulletin, 52(3). https://doi.org/10.1093/schbul/sbag038

Vancouver

Laurikainen H, Armio RL, Tuominen L, Nyman M, Kirjavainen A, Rajander J, et al. The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis. Schizophrenia Bulletin. 2026;52(3). doi:10.1093/schbul/sbag038

BibTeX
@article{Laurikainen2026,
  author = {Laurikainen, Heikki and Armio, Reetta-Liina and Tuominen, Lauri and Nyman, Mikko and Kirjavainen, Anna and Rajander, Johan and Haaparanta-Solin, Merja and Solin, Olof and Hietala, Jarmo},
  title = {The Brain Endocannabinoid System is Differentially Regulated in Male and Female Patients with First-Episode Psychosis},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {3},
  doi = {10.1093/schbul/sbag038}
}
Kostenlos starten →